Exelixis (EXEL) Fundamental Analysis: Revenue, Earnings & Valuation

4.13 / 10

Netural

Fundamental score is 4.1/10, indicating fair health. Strengths include low cost‑of‑sales ratio and manageable current‑liabilities share. Inventory turnover is decent. Weaknesses arise from PB‑ROE misalignment and modest asset‑MV gaps. Overall judgment remains guarded.

Analysis Checks(9/10)

Revenue-MV

Value-0.67

Score3/3

Weight36.23%

1M Return8.11%

Total operating revenue (YoY growth rate %)

Value6.98

Score2/3

Weight0.50%

1M Return0.13%

Inventory turnover ratio

Value3.80

Score2/3

Weight-4.13%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value59.38

Score2/3

Weight1.40%

1M Return0.36%

PB-ROE

Value3.21

Score0/3

Weight12.20%

1M Return2.74%

Long-term debt to working capital ratio (%)

Value0.27

Score3/3

Weight3.17%

1M Return0.87%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score2/3

Weight-4.20%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value6.98

Score2/3

Weight0.20%

1M Return0.05%

Cost of sales ratio (%)

Value3.61

Score3/3

Weight1.05%

1M Return0.26%

Asset-MV

Value-0.55

Score2/3

Weight53.58%

1M Return11.12%

Is EXEL undervalued or overvalued?

EXEL scores 4.13/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 33.73% net margin, 14.23 P/E ratio, 5.15 P/B ratio, and 0.00% earnings growth, these metrics solidify its Netural investment rating.